Stockreport

Orgenesis and ExcellaBio Announce Breakthrough Manufacturing Process for Bioxomes™, Proprietary Synthetic Exosomes/Extracellular Vesicles (EV)

Orgenesis Inc.  (ORGS) 
NASDAQ:AMEX Investor Relations: orgenesis.com
PDF GERMANTOWN, Md., March 31, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering, global biotech company committed to low [Read more]